El Sherif A*, Elgazar M, Sweed D, Ayoub I, Yassein T and Abo El Ella K
DOI: 10.37421/2573-4563.2023.7.219
Hepatocellular Carcinoma (HCC) is one of the leading causes of death from cancer in the world. Direct-acting Antiviral (DAA) therapy has revolutionized the treatment of Hepatitis C Virus (HCV) infection, with very high rates of Sustained Virology Response (SVR) and an excellent safety profile. The procedures performed were: 22 cases done major RT hepatectomies (32.4%). 12 cases underwent Lt Lateral hepatectomy (17.6%) 34 cases underwent non anatomical resection (50%). Time of hepatic transection was performed is 192 min average range (135 to 250 min). The average blood loss was 825 ml (range 50-1600 ml).
The treatment approach for Hepatocellular Carcinoma (HCC) depends on the stage and extent of disease, the severity of the underlying liver disease, and the overall performance status of the patient.
DOI: 10.37421/2573-4563.2024.8.278
Wim Laleman
Shounak Majumder*
Akihisa Fukuda*
Masamitsu Sanui*
Michael Ladna
Yasutaka Kato*
Yanna Cao
Tien Ko
Hepatology and Pancreatic Science received 34 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 